It’s ironic that while drug manufacturers are investing in Pennsylvania by building additional research and manufacturing facilities in the state, many of us can’t afford the medications that are being researched, marketed and produced in the commonwealth.
A recent report by the Pharmaceutical Reform Alliance outlines the dodgy tactics drug manufacturers employ to boost profits at our expense. For instance, pharmaceutical companies pay generic companies — sometimes hundreds of millions of dollars — to prevent lower-cost alternatives from being sold to us.
Big Pharma dramatically increases the price of common drugs each year when the increases in costs don’t justify it. This January, drugmakers unilaterally increased prices on 948 drugs, including those that treat cancer and type 2 diabetes, not to mention common antibiotics.
Congress has not done anything to protect the American consumer by holding Big Pharma accountable. Americans are being pinched economically from every angle. It’s time Congress passes some commonsense reforms, such as Most Favored Nation drug pricing to lower prescription drug prices for Americans, and stop Big Pharma’s profits-over-people business practices.
Joseph Cusick
Baldwin Borough




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.